The insider selling is routine and negligible relative to market cap. No bearish signal. Monitor for any upcoming corporate events (earnings, product announcements) that could explain the timing, but the pattern is consistent with planned option exercises. No immediate trading action warranted.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 1 $170.77entry
- T+1 · 5mo ago −1.63%α −1.50% · $167.98
- T+5 · 4mo ago −4.60%α −4.86% · $162.92
- T+20 · 4mo ago −15.64%α −13.45% · $144.07
- T+60 · 8w ago +3.33%α +0.45% · $176.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Guardant Health insiders sold a total of $10.1M in shares over a one-week window, with the Co-CEO accounting for $9.64M of that total. The sales represent only ~0.05% of the company's $20.4B market cap and are consistent with routine option exercise and tax-related selling. The dollar amount is trivial relative to market cap, and the pattern (option exercises followed by same-day sales) suggests planned liquidity rather than a bearish signal.
Key Financial Metrics
Key Facts
- Co-CEO AmirAli Talasaz sold 64,037 shares at $150.49 for $9.64M on June 26, 2026
- Two directors sold small amounts: Myrtle Potter (1.6K shares, $204K) and Musa Tariq (2.0K shares, $256K)
- Total insider selling of $10.1M is only 0.05% of GH's $20.4B market cap
- CEO's sales followed derivative exercises (non-cash and at $4.18 strike), typical of tax/planning transactions
- Additional CEO sales of $3.89M on June 29 (outside cluster window) bring total recent selling to ~$14M, still <0.07% of market cap
Financial Impact
Insider selling of $10.1M (0.05% of market cap) is immaterial
Risk Factors
- Further insider selling could emerge if the stock continues to rise, but current levels are not alarming
- Insider selling may be misinterpreted by the market as a negative signal despite the small size
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GH-1782854054527 |
Track record
38 reports on GH
3 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +22.49% at T+60 after the May 27, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $145.04 Now $144.03 −0.70% settles Dec 16
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $151.70 Now $144.03 −5.06% settles Dec 14
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $150.87 Now $144.03 −4.53% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $153.43 Now $144.03 −6.13% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $168.58 Now $144.03 −14.56% settles Dec 3
- Nov 3, 202613d ago 8-K Neutral 2/10 Entry $175.00 Now $144.03 −17.70% settles Dec 2
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $162.94 Now $144.03 −11.61% settles Nov 19
- Oct 14, 20264w ago 144 Neutral 2/10 Entry $165.88 to $154.86 Now $144.03 −13.17% ▼ −6.64% −4.74% vs SPY
- Sep 17, 20268w ago Insider Cluster Bearish 5/10 Entry $179.38 to $158.60 Now $144.03 +19.71% ▲ +11.58% +11.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers